Enanta Pharmaceuticals Statistics
Total Valuation
ENTA has a market cap or net worth of $126.76 million. The enterprise value is $149.53 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTA has 21.38 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 21.38M |
| Shares Outstanding | 21.38M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 6.70% |
| Owned by Institutions (%) | 61.80% |
| Float | 14.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.95 |
| Forward PS | 4.06 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.29, with a Debt / Equity ratio of 2.31.
| Current Ratio | 5.29 |
| Quick Ratio | 5.09 |
| Debt / Equity | 2.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.86 |
Financial Efficiency
Return on equity (ROE) is -74.26% and return on invested capital (ROIC) is -18.09%.
| Return on Equity (ROE) | -74.26% |
| Return on Assets (ROA) | -17.33% |
| Return on Invested Capital (ROIC) | -18.09% |
| Return on Capital Employed (ROCE) | -36.86% |
| Revenue Per Employee | $492,084 |
| Profits Per Employee | -$735,992 |
| Employee Count | 131 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.38% in the last 52 weeks. The beta is 0.82, so ENTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -50.38% |
| 50-Day Moving Average | 5.49 |
| 200-Day Moving Average | 8.09 |
| Relative Strength Index (RSI) | 55.39 |
| Average Volume (20 Days) | 119,231 |
Short Selling Information
The latest short interest is 2.85 million, so 13.35% of the outstanding shares have been sold short.
| Short Interest | 2.85M |
| Short Previous Month | 2.96M |
| Short % of Shares Out | 13.35% |
| Short % of Float | 19.88% |
| Short Ratio (days to cover) | 16.81 |
Income Statement
In the last 12 months, ENTA had revenue of $64.46 million and -$96.42 million in losses. Loss per share was -$4.54.
| Revenue | 64.46M |
| Gross Profit | 64.46M |
| Operating Income | -102.11M |
| Pretax Income | -118.12M |
| Net Income | -96.42M |
| EBITDA | -98.94M |
| EBIT | -102.11M |
| Loss Per Share | -$4.54 |
Full Income StatementBalance Sheet
The company has $193.38 million in cash and $216.14 million in debt, giving a net cash position of -$22.77 million or -$1.07 per share.
| Cash & Cash Equivalents | 193.38M |
| Total Debt | 216.14M |
| Net Cash | -22.77M |
| Net Cash Per Share | -$1.07 |
| Equity (Book Value) | 93.54M |
| Book Value Per Share | 4.38 |
| Working Capital | 196.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$55.46 million and capital expenditures -$26.78 million, giving a free cash flow of -$82.24 million.
| Operating Cash Flow | -55.46M |
| Capital Expenditures | -26.78M |
| Free Cash Flow | -82.24M |
| FCF Per Share | -$3.85 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -158.40% and -149.57%.
| Gross Margin | 100.00% |
| Operating Margin | -158.40% |
| Pretax Margin | -153.41% |
| Profit Margin | -149.57% |
| EBITDA Margin | -153.49% |
| EBIT Margin | -158.40% |
| FCF Margin | n/a |
Dividends & Yields
ENTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | -76.06% |
| FCF Yield | -64.88% |
Analyst Forecast
The average price target for ENTA is $17.25, which is 192.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 192.13% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | -0.37% |
| EPS Growth Forecast (5Y) | 8.67% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ENTA has an Altman Z-Score of -1.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.12 |
| Piotroski F-Score | 2 |